BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28134635)

  • 21. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation.
    Fisher RS; Bromer MQ; Thomas RM; Cohen S; Krevsky B; Horwitz B; Glazier KD; Das K; Das KM
    Am J Gastroenterol; 2003 Sep; 98(9):1945-51. PubMed ID: 14499770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining endoscopic submucosal dissection and endoscopic mucosal resection to treat neoplasia in Barrett's esophagus.
    Holmes I; Hing T; Friedland S
    Surg Endosc; 2016 Dec; 30(12):5330-5337. PubMed ID: 27071930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of carbon dioxide cryotherapy for treatment of neoplastic Barrett's esophagus.
    Canto MI; Shin EJ; Khashab MA; Molena D; Okolo P; Montgomery E; Pasricha P
    Endoscopy; 2015 Jul; 47(7):582-91. PubMed ID: 25826275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up results of stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia.
    Belghazi K; van Vilsteren FGI; Weusten BLAM; Meijer SL; Bergman JJGHM; Pouw RE
    Gastrointest Endosc; 2018 Jan; 87(1):77-84. PubMed ID: 28455160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.
    van Vilsteren FG; Pouw RE; Seewald S; Alvarez Herrero L; Sondermeijer CM; Visser M; Ten Kate FJ; Yu Kim Teng KC; Soehendra N; Rösch T; Weusten BL; Bergman JJ
    Gut; 2011 Jun; 60(6):765-73. PubMed ID: 21209124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency Ablation of Barrett's Esophagus: Efficacy, Complications, and Durability.
    Visrodia K; Zakko L; Wang KK
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):491-501. PubMed ID: 28577770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic submucosal tunnel dissection for superficial esophageal neoplastic lesions: a meta-analysis.
    Li P; Ma B; Gong S; Zhang X; Li W
    Surg Endosc; 2020 Mar; 34(3):1214-1223. PubMed ID: 31161293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus.
    Small AJ; Sutherland SE; Hightower JS; Guarner-Argente C; Furth EE; Kochman ML; Forde KA; Bewtra M; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2015 May; 81(5):1158-66.e1-4. PubMed ID: 25650071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma and precancerous lesions.
    Wang J; Zhu XN; Zhu LL; Chen W; Ma YH; Gan T; Yang JL
    World J Gastroenterol; 2018 Jul; 24(26):2878-2885. PubMed ID: 30018482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.
    Cotton CC; Wolf WA; Overholt BF; Li N; Lightdale CJ; Wolfsen HC; Pasricha S; Wang KK; Shaheen NJ;
    Gastroenterology; 2017 Sep; 153(3):681-688.e2. PubMed ID: 28579538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
    Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
    Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett's esophagus (with video).
    Canto MI; Shaheen NJ; Almario JA; Voltaggio L; Montgomery E; Lightdale CJ
    Gastrointest Endosc; 2018 Sep; 88(3):438-446.e2. PubMed ID: 29626424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia.
    Chevaux JB; Piessevaux H; Jouret-Mourin A; Yeung R; Danse E; Deprez PH
    Endoscopy; 2015 Feb; 47(2):103-12. PubMed ID: 25412090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study.
    Phoa KN; Pouw RE; van Vilsteren FGI; Sondermeijer CMT; Ten Kate FJW; Visser M; Meijer SL; van Berge Henegouwen MI; Weusten BLAM; Schoon EJ; Mallant-Hent RC; Bergman JJGHM
    Gastroenterology; 2013 Jul; 145(1):96-104. PubMed ID: 23542068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.
    Phoa KN; van Vilsteren FG; Weusten BL; Bisschops R; Schoon EJ; Ragunath K; Fullarton G; Di Pietro M; Ravi N; Visser M; Offerhaus GJ; Seldenrijk CA; Meijer SL; ten Kate FJ; Tijssen JG; Bergman JJ
    JAMA; 2014 Mar; 311(12):1209-17. PubMed ID: 24668102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective multicenter study using a new multiband mucosectomy device for endoscopic resection of early neoplasia in Barrett's esophagus.
    Pouw RE; Beyna T; Belghazi K; Koch AD; Schoon EJ; Haidry R; Weusten BL; Bisschops R; Shaheen NJ; Wallace MB; Marcon N; Heise-Ginsburg R; Gotink AW; Wang KK; Leggett CL; Ortiz-Fernández-Sordo J; Ragunath K; DiPietro M; Pech O; Neuhaus H; Bergman JJ
    Gastrointest Endosc; 2018 Oct; 88(4):647-654. PubMed ID: 30220300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.
    Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of esophageal stricture after endoscopic submucosal dissection: a systematic review and meta-analysis.
    Oliveira JF; Moura EG; Bernardo WM; Ide E; Cheng S; Sulbaran M; Santos CM; Sakai P
    Surg Endosc; 2016 Jul; 30(7):2779-91. PubMed ID: 26487197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoplastic Barrett's oesophagus and long-term follow-up after endoscopic therapy: complete histological eradication of Barrett associated with high-grade dysplasia significantly decreases neoplasia relapse.
    Caillol F; Godat S; Autret A; Bories E; Pesenti C; Ratone JP; Poizat F; Guiramand J; Delpero JR; Giovannini M
    Surg Endosc; 2016 Dec; 30(12):5410-5418. PubMed ID: 27129553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.